MorphoSys AG banner

MorphoSys AG
XETRA:MOR

Watchlist Manager
MorphoSys AG Logo
MorphoSys AG
XETRA:MOR
Watchlist
Price: 67.25 EUR 0.37% Market Closed
Market Cap: €2.5B

Wall Street
Price Targets

MOR Price Targets Summary
MorphoSys AG

There are no price targets for MOR.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
MorphoSys AG Competitors:
Price Targets
NCSM
NCS Multistage Holdings Inc
27% Upside
BTBT
Bit Digital Inc
216% Upside
ELAN
Elanco Animal Health Inc
5% Upside
INO
Inovio Pharmaceuticals Inc
378% Upside

Revenue
Forecast

11% / Year
Past Growth
24% / Year
Estimated Growth
Estimates Accuracy
1%
Average Beat
11% / Year
Past Growth
24% / Year
Estimated Growth
Estimates Accuracy
1%
Average Beat

For the last 8 years the compound annual growth rate for MorphoSys AG's revenue is 11%. The projected CAGR for the next 3 years is 24%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-16%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-16%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-13%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-13%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MOR's stock price target?
Not Available

MOR doesn't have any price targets made by Wall Street professionals.

What is MorphoSys AG's Revenue forecast?
Projected CAGR
24%

For the last 8 years the compound annual growth rate for MorphoSys AG's revenue is 11%. The projected CAGR for the next 3 years is 24%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett